Kong Seung-Yeon, Cho Mi-Kyoung
Referral Center, Chungbuk National University Hospital, Cheongju 28644, Republic of Korea.
Department of Nursing Science, Chungbuk National University, Cheongju 28644, Republic of Korea.
Healthcare (Basel). 2024 Feb 29;12(5):571. doi: 10.3390/healthcare12050571.
As the prevalence of diabetes is rapidly increasing, the use of continuous glucose monitoring, which is effective in improving glycemic control in type 2 diabetes, is increasing.
Systematic review was performed according to PRISMA criteria. The search was conducted for articles published until 31 May 2023 in PubMed, CINAHL, Cochrane Library, EMBASE, ClinicalKey, etc. The meta-analysis involved the synthesis of effect size; tests of homogeneity and heterogeneity; trim and fill plot; Egger's regression test; and Begg's test for assessing publication bias.
491 studies were searched, of which 17 studies that met the selection criteria were analyzed. The overall effect on HbA1c was -0.37 (95% CI, -0.63~-0.11, < 0.001), with HbA1c decreasing significantly after CGM interventions. Sub-analyses showed that the study was statistically significant in those aged 60 years or older, when rt-CGM was used and when the study was performed in multiple centers.
The results of this study showed that intervention using CGM was effective in reducing HbA1c in type 2 diabetes. The factors identified in this study can be used as guidelines for developing future CGM intervention programs.
随着糖尿病患病率迅速上升,在改善2型糖尿病血糖控制方面有效的持续葡萄糖监测的使用也在增加。
根据PRISMA标准进行系统评价。在PubMed、CINAHL、Cochrane图书馆、EMBASE、ClinicalKey等数据库中检索截至2023年5月31日发表的文章。荟萃分析涉及效应量的合成;同质性和异质性检验;修剪和填充图;Egger回归检验;以及用于评估发表偏倚的Begg检验。
共检索到491项研究,其中17项符合入选标准的研究被纳入分析。对糖化血红蛋白(HbA1c)的总体效应为-0.37(95%可信区间,-0.63~-0.11,P<0.001),持续葡萄糖监测(CGM)干预后HbA1c显著降低。亚组分析显示,在60岁及以上人群、使用实时CGM以及在多中心开展的研究中,该研究具有统计学意义。
本研究结果表明,使用CGM进行干预可有效降低2型糖尿病患者的HbA1c。本研究确定的因素可作为制定未来CGM干预方案的指导原则。